From monitoring to preservation

Preempt intradialytic hypotension stabilization.

Diaprobe is a closed-loop wearable that actively queries venous return in real time and delivers neuromuscular stimulation when early signatures of a crash appear, helping protect patients from IDH and keep treatments on track.

Deployment

< 30 seconds

Anatomically indexed sleeve for fast placement.

Loop speed

Real-time

Active sensing plus immediate stabilization.

Noise control

Sensor fusion

Multi-modal logic to reduce false alarms.

A proactive preservation model

Diaprobe is designed to detect the start of hemodynamic instability before a symptomatic crash, then act immediately.

Predictive diagnostics

Query-based diagnostics evaluates compensatory reserve using a captured "venous return echo," instead of waiting for late downstream changes.

Autonomous intervention

Automated stabilization delivers therapeutic stimulation to support venous return, helping preserve MAP and stroke volume.

Designed for workflow

Single-wrap, shin-indexed placement supports rapid deployment with minimal training burden for staff.

Better at every step

Better detection, better comfort, better serviceability.

OthersBefore
  • Late detection of impending IDH
  • Pain during measurement
  • Uncomfortable and limiting
  • Attached to dialysis machine
  • Hard to service
  • No reaction capability
DiaprobeAfter
  • Real-time IDH detection
  • No pain during measurement
  • Comfortable and wearable
  • Easily reparible separate unit
  • Rapid deployment
  • Active stabilization response

Built for dialysis realities

Fast setup, low alarm fatigue, and a path to measurable outcomes.

What Diaprobe is designed to reduce

  • Late detection of impending IDH
  • Current solution discomfort
  • Early termination of dialysis sessions
  • Staff burden at chairside

What clinics are designed to gain

Outcomes depend on clinical validation, patient factors, and protocols.
  • Improved treatment completion rate
  • Operational simplicity at chairside
  • Clearer hemodynamic trend visibility
  • A scalable pathway for trials and rollout

Next steps

Explore the system, then reach out for partnership or pilots.